Tactile Systems Technology, Inc. announced on January 13, 2025, the appointment of Laura King to its Board of Directors, effective immediately. Ms. King will also serve as a member of the Audit and Compliance & Reimbursement Committees.
Ms. King brings extensive experience as a seasoned healthcare executive, including a 22-year career at General Electric Company (GE). There, she served as a Company Officer and President & CEO of GE Healthcare’s Global Interventional Business.
Her background also includes co-founding BiaCure, Inc. and Elucent Medical, and serving as CEO of NeuWave Medical, which was acquired by Johnson & Johnson’s MedTech division. Her expertise in innovative medical technologies is expected to benefit Tactile Medical's strategic initiatives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.